Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Immunodeficient Patients with Secondary Lung… >
Immunodeficient Patients with Secondary Lung Disease Benefit from Combined Chemotherapy

Published: August 30, 2012.
By Medical College of Wisconsin
http://www.mcw.edu

A team of researchers at the Medical College of Wisconsin and Children's Hospital of Wisconsin Research Institute defined a new treatment for a potentially fatal lung disease in patients with a primary immunodeficiency known as common variable immunodeficiency (CVID).The findings are published in the Journal of Clinical Immunology.

Common variable immunodeficiency (CVID) is the most common primary immunodeficiency that requires regular treatment with medication, specifically immunoglobulin (antibodies) replacement therapy. With immunoglobulin therapy, deaths from infection in patients with CVID have decreased and deaths due to non-infectious complications have increased. One of the most frequent causes of death now in CVID is a lung disease known as granulomatous-lymphocytic interstitial lung disease (GLILD). In GLILD, white blood cells abnormally accumulate in the lung, which leads to a progressive decline in lung function and, eventually, respiratory failure. The researchers evaluated patients with GLILD to see if rituximab and azathioprine (combination chemotherapy) would improve pulmonary function and/or radiographic abnormalities by killing these white blood cells in the lung.

"The most common medication used for GLILD are corticosteroids but in our hands this type of medication did not clear the disease. Therefore, we designed therapy aimed at killing the specific type of lymphocytes, B cells and T cells, we found in abnormal numbers in the lung biopsies we examined. We reasoned if we killed the lymphocytes in the lung, lung function and radiographic abnormalities would both improve, which is what we found." said John M. Routes, M.D., professor and chief of asthma, allergy and immunology at the Medical College of Wisconsin (MCW), medical director of allergy/clinical immunology at Children's Hospital and researcher at the Research Institute.


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Asthma 
7/13/10 
Interferon Might Help Asthma Patients Breathe Easier, UT Southwestern Study Suggests
By UT Southwestern Medical Center
DALLAS – July 15, 2010 – An immune-system protein already used to treat diseases like multiple sclerosis, hepatitis C and a variety of cancers might also aid asthma patients, …
Cells 
5/28/10 
Those with Allergic Asthma Face Double Trouble During Flu Season, UT Southwestern Findings Suggest
By UT Southwestern Medical Center
DALLAS – June 1, 2010 – New research from UT Southwestern Medical Center suggests that allergic reactions to pet dander, dust mites and mold may prevent people with allergic …
Umetsu 
5/30/11 
Why Does Flu Trigger Asthma?
By Children's Hospital Boston
Boston, Mass. - When children with asthma get the flu, they often land in the hospital gasping for air. Researchers at Children's Hospital Boston have found a previously unknown …
Cells 
7/6/12 
★★★ 
Rewiring DNA Circuitry Could Help Treat Asthma
By Walter and Eliza Hall Institute
Reprogramming asthma-promoting immune cells in mice diminishes airway damage and inflammation, and could potentially lead to new treatments for people with asthma, researchers have found. …
Cat 
3/10/11 
Nottingham Scientists Identify Trigger in Cat Allergy
By University of Nottingham
A breakthrough by scientists at The University of Nottingham could provide hope for any allergy sufferers who have ever had to choose between their health and their household pet. …
Interferon 
6/16/14 
Cellular Force That Drives Allergy And Asthma Can Be Blocked by Interferon
By UT Southwestern Medical Center
DALLAS – June 16, 2014 – A mechanism that could underlie the development of cells that drive asthma and allergies has been uncovered by immunology researchers at UT Southwestern Medical …
Cells 
6/2/14 
Common Cholesterol Drug Greatly Alters Inflammatory Response to Common Cold
By Federation of American Societies for Experimental Biology
Cold season may be just behind us, but a new discovery may shed light on how this common condition triggers asthma attacks. In a new research report published in …
Immune 
2/16/12 
New Molecule Discovered in Fight Against Allergy
By University of Nottingham
Scientists at The University of Nottingham have discovered a new molecule that could offer the hope of new treatments for people allergic to the house dust mite. The …
System 
4/10/14 
Enzyme Revealed as Promising Target to Treat Asthma And Cancer
By Johns Hopkins Medicine
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition
All contents are copyright of their owners except U.S. Government works. U.S. Government works are assumed to be in the public domain unless otherwise noted. Everything else copyright ScienceNewsline.